Nakamoto, Nobuhiro, Cho, Hyosun, Shaked, Abraham, Olthoff, Kim, Valiga, Mary E., Kaminski, Mary, Gostick, Emma, Price, David  ORCID: https://orcid.org/0000-0001-9416-2737, Freeman, Gordon J., Wherry, E. John and Chang, Kyong-Mi
      2009.
      
      Synergistic reversal of intrahepatic hcv-specific cd8 t cell exhaustion by combined pd-1/ctla-4 blockade.
      PLoS Pathogens
      5
      
        (2)
      
      
      , e1000313.
      10.1371/journal.ppat.1000313
    
  
  
         | 
      
Preview  | 
          
            
PDF
 - Published Version
   Available under License Creative Commons Attribution. Download (2MB) | Preview  | 
        
Abstract
Viral persistence is associated with hierarchical antiviral CD8 T cell exhaustion with increased programmed death-1 (PD-1) expression. In HCV persistence, HCV-specific CD8 T cells from the liver (the site of viral replication) display increased PD-1 expression and a profound functional impairment that is not reversed by PD-1 blockade alone. Here, we report that the inhibitory receptor cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) is preferentially upregulated in PD-1+ T cells from the liver but not blood of chronically HCV-infected patients. PD-1/CTLA-4 co-expression in intrahepatic T cells was associated with a profound HCV-specific effector dysfunction that was synergistically reversed by combined PD-1/CTLA-4 blockade in vitro, but not by blocking PD-1 or CTLA-4 alone. A similar effect was observed in circulating HCV-specific CD8 T cells with increased PD-1/CTLA-4 co-expression during acute hepatitis C. The functional response to combined blockade was directly associated with CTLA-4 expression, lost with CD28-depletion and CD4-independent (including CD4+FoxP3+ Tregs). We conclude that PD-1 and CTLA-4 pathways both contribute to virus-specific T cell exhaustion at the site of viral replication by a redundant mechanism that requires combined PD-1/CTLA-4 blockade to reverse. These findings provide new insights into the mechanisms of virus-specific T cell dysfunction, and suggest that the synergistic effect by combined inhibitory receptor blockade might have a therapeutic application against chronic viral infection in vivo, provided that it does not induce autoimmunity.
| Item Type: | Article | 
|---|---|
| Date Type: | Publication | 
| Status: | Published | 
| Schools: | Schools > Medicine Research Institutes & Centres > Systems Immunity Research Institute (SIURI)  | 
      
| Subjects: | Q Science > QR Microbiology > QR180 Immunology R Medicine > R Medicine (General) R Medicine > RB Pathology  | 
      
| Publisher: | Public Library of Science | 
| ISSN: | 1553-7374 | 
| Date of First Compliant Deposit: | 30 March 2016 | 
| Last Modified: | 16 May 2023 04:09 | 
| URI: | https://orca.cardiff.ac.uk/id/eprint/28798 | 
Citation Data
Cited 290 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]()  | 
              Edit Item | 

							



 Altmetric
 Altmetric